000 | 01982 a2200493 4500 | ||
---|---|---|---|
005 | 20250515094430.0 | ||
264 | 0 | _c20080508 | |
008 | 200805s 0 0 eng d | ||
022 | _a0091-3057 | ||
024 | 7 |
_a10.1016/j.pbb.2007.10.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBishnoi, Mahendra | |
245 | 0 | 0 |
_aProtective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. _h[electronic resource] |
260 |
_bPharmacology, biochemistry, and behavior _cFeb 2008 |
||
300 |
_a511-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
650 | 0 | 4 | _aAnti-Dyskinesia Agents |
650 | 0 | 4 |
_aAntipsychotic Agents _xantagonists & inhibitors |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
650 | 0 | 4 |
_aCatalase _xmetabolism |
650 | 0 | 4 |
_aCurcuma _xchemistry |
650 | 0 | 4 |
_aCurcumin _xtherapeutic use |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xprevention & control |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 |
_aHaloperidol _xantagonists & inhibitors |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
650 | 0 | 4 |
_aNeurotransmitter Agents _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aStereotyped Behavior _xdrug effects |
650 | 0 | 4 |
_aSulfhydryl Compounds _xmetabolism |
650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
700 | 1 | _aChopra, Kanwaljit | |
700 | 1 | _aKulkarni, Shrinivas K | |
773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 88 _gno. 4 _gp. 511-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pbb.2007.10.009 _zAvailable from publisher's website |
999 |
_c17538957 _d17538957 |